5148.5000 3.50 (0.07%)
NSE Nov 20, 2026 10:19 AM
Volume: 20,260
 

5148.50
0.07%
ICICI Securities Limited
Alkem Laboratories (Alkem) delivered a strong Q2FY26 result led by traction across regions. Growth in India biz (+12% YoY) was led by better traction in chronic therapies and recent foray in medical devices segment, while new launches including gEntresto boosted US revenue (+28%).
Alkem Laboratories Ltd. is trading below all available SMAs
More from Alkem Laboratories Ltd.
Recommended